Amcon Distributing Co's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 28 out of 30 in the Food & Drug Retailing industry.Institutional ownership is very high.In the medium term, the stock price is expected to remain stable.The company has shown weak stock market performance over the past month, in line with its weak fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Media Coverage
The current financial score of Amcon Distributing Co is 5.23, ranking 28 out of 30 in the Food & Drug Retailing industry. Its financial status is weak, and its operating efficiency is average. Its latest quarterly revenue reached 577.65M, representing a year-over-year increase of 17.08%, while its net profit experienced a year-over-year increase of 36.76%.
Key Metrics
The current valuation score of Amcon Distributing Co is 5.76, ranking 27 out of 30 in the Food & Drug Retailing industry. Its current P/E ratio is 166.97, which is 17.53% below the recent high of 196.23 and 100.00% above the recent low of 0.00.
No earnings forecast score is currently available for Amcon Distributing Co. The Food & Drug Retailing industry's average is 7.52.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
The current price momentum score of Amcon Distributing Co is 5.87, ranking 26 out of 30 in the Food & Drug Retailing industry. Currently, the stock price is trading between the resistance level at 91.06 and the support level at 73.47, making it suitable for range-bound swing trading.
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
The current institutional shareholding score of Amcon Distributing Co is 3.00, ranking 15 out of 30 in the Food & Drug Retailing industry. The latest institutional shareholding proportion is 10.63%, representing a quarter-over-quarter decrease of 7.94%. The largest institutional shareholder is James Simons, holding a total of 14.00K shares, representing 1.43% of shares outstanding, with 1.43% decrease in holdings.
The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Food & Drug Retailing domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Amcon Distributing Co is 2.37, ranking 22 out of 30 in the Food & Drug Retailing industry. The company's beta value is -0.21. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.
